SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is drawing attention amid a sharp selloff and repeated lows, with traders citing weakness across quantum stocks and concerns about high valuations, losses, and the long path to commercial adoption. Some see the decline as a buying opportunity and point to D-Waves deployments and partnerships, while others remain skeptical that near-term business progress can support the valuation.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Brazilian equities sold off sharply after Lulas reelection, weighing on NU as traders reassessed political and macroeconomic risks in its core market. The community is divided between viewing the drop as an overreaction to the election, with the business fundamentals intact, and worrying that Brazil-related risks could prolong the weakness.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

Shares are under pressure as traders react to weak early sales for AstraZenecas competing hypertension drug, Baxfendy, and limited insurance coverage, fueling doubts about lorundrostats commercial prospects. Some investors argue the launch is still in an early coverage ramp and see upcoming data and the FDA decision as important milestones; others worry Mineralys may struggle to compete on its own.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is falling amid a broad semiconductor selloff after Intels weak forward guidance heightened concerns about PC demand and industry conditions. Traders point to the drop across chip peers, while some see the pullback as a buying opportunity ahead of Qualcomms earnings report.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after a breakout to a fresh 52-week high, with traders positioning ahead of the Q3 report and watching BRIUMVI sales growth and guidance. Buyout and short-squeeze theories are also circulating, though some investors view the move as momentum ahead of earnings rather than evidence of a deal.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charters Q2 results have intensified debate over persistent broadband subscriber losses, competition and heavy debt, with concerns about weaker cash generation and paused buybacks weighing on sentiment. Bulls counter that the stocks low valuation, mobile growth and the Cox merger could support a recovery, while others remain skeptical about the deals added financing and dilution.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons third-quarter results beat expectations, with strong refining profits and record operating performancesupported by elevated fuel margins amid supply disruptionsdriving the shares higher. Traders welcomed the results and shareholder-return plans, though some noted the stocks modest reaction and bearish put-heavy options activity.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

Traders are weighing growth in onsemis Other end-market bucket, which includes computing and AI data-center demand, against concerns that long-term supply agreements can be changed or canceled. The discussion is split between buyers viewing the pullback as an opportunity and skeptics pointing to weak auto and industrial demand and questioning how durable the AI-related growth will be.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Attention centers on Aduros progress toward commercializing its Hydrochemolytic Technology, including pilot results on mixed polyolefin feedstocks and engineering work for its planned Chemelot facility; some investors also see paraffinic crude as a potential nearer-term application. Bullish holders view these as validation, while skeptics argue the company has yet to demonstrate viable economics or commercial-scale performance.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly earnings miss and reduced profit outlook, driven by sharply higher fuel costs, are the main focus. Traders are split between concern that fuel and operating expenses will squeeze margins and optimism that resilient travel demand, premium revenue, and fare increases can offset the pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beyond Air (XAIR) Q1 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Beyond Air (XAIR) Q4 2026 Earnings Call Transcript

Transcript: Beyond Air Q4 2026 Earnings Conference Call

On Friday, Beyond Air (NASDAQ:XAIR) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

Earnings Scheduled For June 26, 2026

Companies Reporting Before The Bell
 Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss at $0.56 per share on revenue of $2.30 million.
 Apogee Enterprises (NASDAQ:APOG) is expected to report quarterlyread more...

Stock Market Today: Dow Jones Inches Up, S&P 500 And Nasdaq Futures Slip As Tech Selloff Gathers Pace Apple, Beyond Air In Focus

U.S. stock futures mixed on Friday, Nasdaq 100 & S&P 500 down, Dow Jones up. Macro data shows strong PCE Index & revised Q1 GDP.read more...

Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag?

Equity

Fresh analyst cuts, delisting fears, and leadership uncertainty pushed all three stocks to 52-week lows despite pockets of retail optimism.


At $150 off, the new MacBook Air is now cheaper than last year's model

Both the 13-inch and 15-inch MacBook Airs are down to new low prices. | Photo: Antonio G. Di Benedetto / The Verge If you were bummed that the new M5-powered MacBook Air cost $100 more than last...

Beyond Air XAIR Q3 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Beyond Air Earnings Preview

XAIR Stock More Than Doubled Today — What’s Driving The Rally?

Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.


Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Beyond Air Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Lucid fell to a new low after weak revenue guidance, a $300 million stock offering, and multiple analyst price target cuts.</li><li>Beyond Air hit a fresh low after receiving a Nasdaq warning over its sub-$1 share price.</li><li>Conagra Brands slid after naming a new CEO, with analysts warning several macroeconomic factors could keep earnings under pressure.</li></ul>Shares of Lucid Group, Beyond Air, and Conagra Brands each hit fresh 52-week intraday lows on Wednesday, driven by distinct catalysts. XAIR continued its slide in overnight trading, while LCID and CAG managed to pare some of their regular session losses.<h1 class="st-heading-1">Why LCID Hit A 52-Week Low</h1>Lucid has been in the headlines all week:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-lucid-stock-rising-new-ceo-strategy/cZJtIR5RIvu">naming</a> a new CEO, securing fresh funding from Saudi Arabia's sovereign wealth fund, and inking a robotaxi partnership with Uber. But investor sentiment has soured on the back of a significantly weaker-than-expected revenue outlook for the current quarter and a $300 million stock offering. The EV maker has yet to turn a profit, nearly 19 years after its founding.Wednesday brought a fresh round of price target cuts. Baird lowered its target to $12 from $14, maintaining a 'Neutral' rating, citing the new CEO appointment and the Uber partnership as reasons to update its model. TD Cowen analyst Itay Michaeli cut his target more sharply, to $10 from $19, while keeping a 'Hold' rating.Despite the pressure, Stocktwits sentiment for&nbsp;<a href="https://stocktwits.com/symbol/LCID">LCID</a> was 'extremely bullish' at the last close, suggesting retail traders are betting on a near-term turnaround following the leadership shakeup. The stock hit an intraday 52-week low of $8.11 on Wednesday and is down over 25% year-to-date.<h1 class="st-heading-1">Why XAIR Hit A 52-Week Low</h1>Beyond Air disclosed on Wednesday that it had received a Nasdaq notice for non-compliance with the $1.00 minimum bid price requirement and has requested a hearing before the Nasdaq Hearings Panel, scheduled for May 14, 2026. Any delisting or suspension is stayed pending the panel's written decision, meaning shares are expected to remain listed until the panel issues its decision. However, there is no assurance that the panel will grant continued listing or that compliance will be regained.The Nasdaq notice compounds a difficult stretch for the medical device and biopharmaceutical company. Last month, CEO Steve Lisi resigned, effective March 27, and the board appointed chief commercial officer Robert Goodman as his replacement. Earlier in March, the company also confirmed that its proposed transaction with XTL Biopharmaceuticals involving Beyond Air's NeuroNOS subsidiary had been terminated after the parties failed to reach a definitive agreement.On Stocktwits, sentiment for&nbsp;<a href="https://stocktwits.com/symbol/XAIR">XAIR</a> was 'bullish' at the last close, with several retail traders predicting the stock will avoid delisting. XAIR hit an intraday 52-week low of $0.43 on Wednesday and has shed 28% year to date.<h1 class="st-heading-1">Why CAG Hit A 52-Week Low</h1>Conagra shares have been sliding since Monday, when the packaged food giant&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cag-stock-crashes-to-near-17-year-lows/cZJ85DBRIun">named</a> a new CEO, less than a month after cutting its annual profit forecast amid mounting uncertainty around global trade. The market's initial read on the leadership change has not been encouraging.JPMorgan analysts described the incoming CEO as well-regarded and knowledgeable, but they still expect earnings pressure to build over the coming quarters as Conagra continues to wrestle with inflationary headwinds in freight and packaging. Jefferies echoed that view, noting that the new CEO's near-term options are limited given the company's high leverage, margin pressures, and exposure to inflation.Retail traders on Stocktwits were 'bullish' on&nbsp;<a href="https://stocktwits.com/symbol/CAG">CAG</a> at the last close, with sentiment partly lifted by news that two directors purchased over $700,000 in shares. The stock hit an intraday 52-week low of $14.04 on Wednesday and has shed nearly 19% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-sp500-nasdaq-futures-trump-us-iran-war-near-end-hims-msft-rum-nflx-xndu/cZJvTEVRIwu">Dow, S&amp;P 500, Nasdaq Futures Rise After Trump Says US-Iran War ‘Very Close To Over</a>

Lucid, Beyond Air, and Conagra hit new 52-week lows, but retail sentiment remains bullish for at least two stocks. | Representative image: Getty Images

Fresh analyst cuts, delisting fears, and leadership uncertainty pushed all three stocks to 52-week lows despite pockets of retail optimism.

Conagra Brands Inc

Lucid Group Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$XAIR 🚨 THIS IS STARTING TO LOOK SERIOUS 🚨 
 
Q3 revenue just hit a RECORD $2.3M — up 30% QoQ and 27% YoY. 
 
And here’s the BIG part: 
 
🔥 2026 revenue guidance: $8M 
🔥 2027 guidance: $16–18M 
🔥 2nd-gen LungFit PH is STILL under FDA review 
🔥 FDA approval could significantly expand the addressable market 
🔥 LungFit adoption is already accelerating 
 
The company literally says it expects demand to increase significantly after FDA approval. 
 
This means the market may be looking at a company BEFORE the real inflection point. 
 
Record revenue + accelerating adoption + FDA catalyst + 2X+ projected revenue growth. 
 
If FDA approval hits and volume starts pouring in… 
 
XAIR could move MUCH faster than people expect. 🚀🔥 
 
Not financial advice. High-risk small cap.

$XAIR I think when the company randomly put out an upgraded revenues the other week, that it could be an indicator that FDA approval for Lungfit PH II isn't far off. The new device will open a lot of doors.

Say Whaaaat

$XAIR THIS COULD GET VERY INTERESTING 
Q3 revenue hit a RECORD $2.3M, up 30% QoQ / 27% YoY. 
2027 revenue guidance remains $16–18M, more than DOUBLE 2026 guidance. 
And the biggest catalyst is still ahead — FDA approval for Gen-2 LungFit PH. 
An insider just bought ~$56K of shares. 
$10 PT is already on the table. 
If FDA approval hits + volume comes in, this could move FAST. 🔥

$XAIR Beyond Air Form 4, Insider action here on Friday late 
 
Yi-Chien Lin (10%+ Owner) Buys 20,393 @ $2.77

AlertsAndNews

$XAIR they inject innocent animals cancer cells to grow them a tumor in order to test their anti cancer drug 
(beyond cancer daughter company )

Hujjkjj

$XAIR this will multibagger november or december 
 
insider buys with own money proof its undervalued under 3

Feed

News

Sentiment

Earnings

Fundamentals

Info

XAIR Beyond Air Inc

Fundamentals

Latest XAIR News